Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03185026
Other study ID # 9808
Secondary ID 2017-A00571-52
Status Recruiting
Phase N/A
First received
Last updated
Start date September 6, 2017
Est. completion date March 6, 2024

Study information

Verified date October 2022
Source University Hospital, Montpellier
Contact Déborah DUCASSE, MD
Phone 00 33 4 67 33 82 89
Email d-ducasse@chu-montpellier.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aims of the recent World Health Organization report, highlighting that every 40 seconds a person dies from suicide somewhere in the world, are to increase awareness on the public health significance of suicide and make suicide prevention a greater priority within the global public health agenda. Across age groups, less than half of individuals at elevated suicide risk interface with some form of mental health services. Several barriers to help-seeking have been identified (maladaptive coping, lack of perceived need, beliefs about treatment effectiveness, fear of hospitalization or mistrust of providers, stigma...), which are key targets in knowledge-based interventions on suicide. Psychoeducational programs have shown effectiveness in prevention relapse for several mental disorders such as schizophrenia, bipolar disorder or recurrent depressive disorder, improving treatment adherence and self-confidence in coping with symptoms of the disease. They are highly recommended for addressing adherence problems in patients with serious and persistent mental illness. Only one team has published a study protocol for a controlled trial assessing a 10 group sessions psychoeducational program for prevention in patients having a suicide history, in a one-year follow-up. Interestingly, diagnosis-mixed group psychoeducation have shown superiority than an unspecific intervention add-on routine care, on the suicide prevention and compliance for severe psychiatric disorders. Those psychoeducational-specific elements are namely the interactive transfer of illness and treatment-related knowledge and management/coping - cognitive/behavioral - strategies, as defined by the National Institute for Health and Care Excellence)-Guidelines (NICE). Notably, as several psychiatric diagnoses are associated with suicidal behavior (SB), coping strategies have to target processes that overlap among these psychiatric disease, as well as suicidal vulnerability. Acceptance and Commitment Therapy (ACT), a "third wave" behavioral therapy, targets experiential avoidance and psychological flexibility, at the core of psychiatric disorders. Interestingly, in patients with a history of suicidal depression, training in mindfulness can help to weaken suicidal thinking associated with depressive symptoms , and thus reduce an important vulnerability for relapse to suicidal depression. ACT would also increase intrinsic motivation for daily life action (i.e. reasons for living and acting). Then, the functional analysis (matrix) used in ACT seems to be an useful tool to help patient in decision making, a neuropsychological factor impaired in suicidal patients. Finally, acceptance and commitment group therapy has suggested effectiveness in reducing intensity and frequency of suicidal thoughts, through improvement in acceptance, in high risk suicidal patients. As compared with ACT, Dialectical behavior therapy (DBT) teaches added distress tolerance in view of survive the crisis. DBT is the most validated therapy for borderline personality disorder, the mental disorder the most associated with SB . Notably, group skills training is the most effective component in DBT for preventing suicidal behavior in borderline patients with high suicidal risk. Furthermore, interventions based on positive psychology have suggested efficacy in reducing depressive symptoms and suicidal ideation. Notably, in a recent pilot study, positive psychology exercises delivered to suicidal inpatients were feasible and associated with short-term gains improvement in optimism and hopelessness. Finally, as altered social link and sense of belonging have been widely involved in SB, relationship skills are an interesting positive psychology area for suicide prevention program. Psychoeducational program integrating knowledge as well the last innovating cognitive-behavioral coping strategies for SB is of major interest in suicide prevention. Investigators developed the first French program of suicide psychoeducation called "PEPSUI". The aim of this innovating program is to teach patients the more recent knowledge about suicidal behaviour (SB) and effective treatments, through didactic and interactive sessions. Thus, the objective is to conduct the patients to become experts and actors of their disease, increasing adherence to treatment. Besides, the patients will experiment the last innovating psychological skills to cope with unpleasant emotions and thoughts (including suicidal thoughts), distress tolerance skills and crisis strategies, and identify personal purpose in life and learn positive psychological skills in order to anchor with meaningful and pleasant components in life. Thus, this program will include skills from ACT, DBT and positive psychology. Finally, this primary care research is about a program which aim at improving accessibility to mental health services, care adherence and continuity for suicidal patients.


Description:

The project aims at to compare the effectiveness on suicide re-attempt rate reduction at 2-years follow-up of add-on PEPSUI psychoeducational program versus relaxation program in patients having attempted suicide in the past year Secondary, the project aims to compare between add-on psychoeducational program and relaxation: - Interrupted or aborted suicide attempt rate reduction during the follow-up - Severity and intensity of suicide ideation: at post-treatment, and at 6, 12, 18 and 24 months after the intervention (and the evolution between pre and each post-intervention point) - Intensity of suicidal intent: at post-treatment, and at 6, 12, 18 and 24 months after the intervention (and the evolution between pre and each post-intervention point) - Adherence to treatment and perceived utility of mental health services: at post-treatment, and at 6, 12, 18 and 24 months after the intervention (and the evolution between pre and each post-intervention point) - Levels of depression, anxiety, psychological pain and hopelessness: at post-treatment, and at 6, 12, 18 and 24 months after the intervention (and the evolution between pre and each post-intervention point) - Global functioning and quality of life: at post-treatment, and at 6, 12, 18 and 24 months after the intervention (and the evolution between pre and each post-intervention point) - Subjective social support: at post-treatment, and at 6, 12, 18 and 24 months after the intervention (and the evolution between pre and each post-intervention point) - The need to emergency psychiatric consultation and psychiatric hospitalisation for suicidal ideation: at post-treatment, and at 6, 12, 18 and 24 months after the intervention (and the evolution between pre and each post-intervention point) - Acceptance, contact with present moment and meaning in life: at post-treatment, and at 6, 12, 18 and 24 months after the intervention (and the evolution between pre and each post-intervention point) - Satisfaction and adherence to the intervention: at post-treatment (likert scale). 500 patients suffering from current suicidal behavior disorder (according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) will be recruited, i.e. having attempted to suicide in the past year. Eligible patients will be randomized in one of the two arms: add-on psychoeducation or add-on relaxation (computer-generated randomisation in a 1 :1 ratio). Sociodemographic data, psychiatric diagnoses using Mini-International Neuropsychiatric Interview (M.I.N.I.) and pharmacological treatment will be also recorded. An independent researcher not involved in the study will perform the allocation. Each patient will be evaluated at baseline (pre intervention V1) and followed-up during 24 months after treatment completion, with 5 visits: post intervention (V2) 6 months (V3), 12 months (V4), 18 months (V5) and 24 months (V6) after the intervention. Blind trained evaluators will assess patients. Patients will be told to avoid saying their group of allocation to the evaluator.


Recruitment information / eligibility

Status Recruiting
Enrollment 500
Est. completion date March 6, 2024
Est. primary completion date March 6, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Between 18 and 65 years - Having a current suicidal behaviour disorder according to DSM-5 (APA, 2013), i.e. history of suicidal attempt in the past year - Able to speak, read and understand French. - Able to give written informed consent - Having signed informed consent - Must belong to social safety system Exclusion Criteria: - Having a current or past diagnosis of an organic mental disorder - Having a lifetime history of schizophrenia - Having a mental retardation - Planned longer stay outside the region that prevents compliance with the visit plan - Deprived of liberty Subject (by judicial or administrative decision) - Protected by law (guardianship) - Current exclusion period in relation to another protocol

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Interventional group : PEPSUI psychoeducational program
The program includes 10 weekly, 2-hours sessions led by two trained animators (nurse, medical doctor/psychologist), each focusing on a specific theme or skill : Education on suicidal behavior (clinic and epidemiology), and conceptualization of the phenomenon on a matrix Education on the suicidal crisis, identification of important life areas and values for the patient, experimentation on the way to use the matrix as a decision-making tool. and 4) Self-assessment of suicidal ideations, coping strategies based on suicide ideation intensity and emotional tension (acceptation, distress tolerance, personal aid kit, and emergency care) 5) Stress-diathesis model of suicidal behavior, innovating cognitive skills (defusion), and valued actions 6) Stress factors (psychiatric diseases and negative life events), resilience, and contact with present moment 7) Suicidal vulnerability, personal strengths 8) Social support, skills to create quality relationships
Other:
Relaxation group
Participants will be included in a standardized relaxation program, consisting of 10 weekly sessions lasting 2 hours. There will be 2 therapists for each patients group. Abdominal and muscular relaxation skills will be experimented.

Locations

Country Name City State
France Uh Montpellier Montpellier

Sponsors (8)

Lead Sponsor Collaborator
University Hospital, Montpellier Centre Psychothérapique de Nancy, FRANCE, CHU Albert Michallon, La Tronche, FRANCE, CHU Gabriel Montpied, Clermont Ferrand, FRANCE, CHU Le Vinatier, Bron, FRANCE, CHU Marius Lacroix, Lille, FRANCE, CHU Pasteur, Nice, FRANCE, CHU Tarnier, Paris, FRANCE

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Suicide re-attempt rate reduction using the Columbia Suicide Severity Rating Scale (C-SSRS) Comparison of suicide re-attempt rate reduction, at 2 years follow-up, between PEPSUI and relaxation groups. At 2 years after the intervention
Secondary Interrupted suicide attempt rate reduction using the C-SSRS Comparison of suicide re-attempt rate reduction, at 2 years follow-up, between PEPSUI and relaxation groups. At 2 years after the intervention
Secondary Aborted suicide attempt rate reduction using the C-SSRS Comparison of suicide re-attempt rate reduction, at 2 years follow-up, between PEPSUI and relaxation groups. At 2 years after the intervention
Secondary Severity of suicide ideation using the C-SSRS Comparison of the severity of suicide ideation between pre-intervention and post-intervention (one week after the last session of the intervention) within the two groups (PEPSUI versus Relaxation). At one week after the intervention
Secondary Severity of suicide ideation using the C-SSRS Comparison of the severity of suicide ideation between pre-treatment and 6 months post-intervention within the two groups (PEPSUI versus Relaxation) At 6 months after the intervention
Secondary Severity of suicide ideation using the C-SSRS Comparison of the severity of suicide ideation between pre-treatment and 12 months post-intervention within the two groups (PEPSUI versus Relaxation). At 12 months after the intervention
Secondary Severity of suicide ideation using the C-SSRS : Comparison of the severity of suicide ideation between pre-treatment and 18 months post-intervention within the two groups (PEPSUI versus Relaxation). At 18 months after the intervention
Secondary Severity of suicide ideation using the C-SSRS Comparison of the severity of suicide ideation between pre-treatment and 24 months post-intervention within the two groups (PEPSUI vs Relaxation). At 24 months after the intervention
Secondary Severity of suicide ideation evaluated by the likert scales from 0 (none) to 10 (maximum possible suicidal ideation) Comparison of the severity of suicide ideation between pre-treatment and one week post-intervention within the two groups (PEPSUI versus Relaxation). At one week after the intervention
Secondary Severity of suicide ideation evaluated by the likert scales from 0 (none) to 10 (maximum possible suicidal ideation) Comparison of the severity of suicide ideation between pre-treatment and 6 months post-intervention within the two groups (PEPSUI versus Relaxation). At 6 months after the intervention
Secondary Severity of suicide ideation evaluated by the likert scales from 0 (none) to 10 (maximum possible suicidal ideation) Comparison of the severity of suicide ideation between pre-treatment and 12 months post-intervention within the two groups (PEPSUI versus Relaxation). At 12 months after the intervention
Secondary Severity of suicide ideation evaluated by the likert scales from 0 (none) to 10 (maximum possible suicidal ideation) Comparison of the severity of suicide ideation between pre-treatment and 18 months post-intervention within the two groups (PEPSUI versus Relaxation). At 18 months after the intervention
Secondary Severity of suicide ideation evaluated by the likert scales from 0 (none) to 10 (maximum possible suicidal ideation) Comparison of the severity of suicide ideation between pre-treatment and 24 months post-intervention within the two groups (PEPSUI versus Relaxation). At 24 months after the intervention
Secondary Intensity of suicide ideation using the Columbia-Suicide Severity Rating Scale (C-SSRS) Comparison of the intensity of suicide ideation between pre-treatment and one week post-intervention within the two groups (PEPSUI versus Relaxation). At one week after the intervention
Secondary Intensity of suicide ideation using the Columbia-Suicide Severity Rating Scale (C-SSRS) Comparison of the intensity of suicide ideation between pre-treatment and 6 months post-intervention within the two groups (PEPSUI versus Relaxation). At 6 months after the intervention
Secondary Intensity of suicide ideation using the Columbia-Suicide Severity Rating Scale (C-SSRS) Comparison of the intensity of suicide ideation between pre-treatment and 12 months post-intervention within the two groups (PEPSUI versus Relaxation). At 12 months after the intervention
Secondary Intensity of suicide ideation using the Columbia-Suicide Severity Rating Scale (C-SSRS) Comparison of the intensity of suicide ideation between pre-treatment and 18 months post-intervention within the two groups (PEPSUI versus Relaxation). At 18 months after the intervention
Secondary Intensity of suicide ideation using the Columbia-Suicide Severity Rating Scale (C-SSRS) Comparison of the intensity of suicide ideation between pre-treatment and 24 months post-intervention within the two groups (PEPSUI versus Relaxation). At 24 months after the intervention
Secondary Intensity of suicide ideation using the likert scales, from 0 (none) to 10 (maximum possible suicidal ideation) Comparison of the intensity of suicidal intent between pre-treatment and one week post-intervention within the two groups (PEPSUI versus Relaxation). At one week after the intervention
Secondary Intensity of suicide ideation using the likert scales, from 0 (none) to 10 (maximum possible suicidal ideation) Comparison of the intensity of suicidal intent between pre-treatment and 6 months post-intervention within the two groups (PEPSUI versus Relaxation). At 6 months after the intervention
Secondary Intensity of suicide ideation using the likert scales, from 0 (none) to 10 (maximum possible suicidal ideation) Comparison of the intensity of suicidal intent between pre-treatment and 12 months post-intervention within the two groups (PEPSUI versus Relaxation). At 12 months after the intervention
Secondary Intensity of suicide ideation using the likert scales, from 0 (none) to 10 (maximum possible suicidal ideation) Comparison of the intensity of suicidal intent between pre-treatment and 18 months post-intervention within the two groups (PEPSUI versus Relaxation). At 18 months after the intervention
Secondary Intensity of suicide ideation using the likert scales, from 0 (none) to 10 (maximum possible suicidal ideation) Comparison of the intensity of suicidal intent between pre-treatment and 24 months post-intervention within the two groups (PEPSUI versus Relaxation). At 24 months after the intervention
Secondary Adherence to treatment using the Medication Adherence Rating Scale (MARS) Comparison of the pharmacological adherence between pre-treatment and one week post-intervention within the two groups (PEPSUI versus Relaxation). At one week after the intervention
Secondary Adherence to treatment using the Medication Adherence Rating Scale (MARS) Comparison of the pharmacological adherence between pre-treatment and 6 months post-intervention within the two groups (PEPSUI versus Relaxation). At 6 months after the intervention
Secondary Adherence to treatment using the Medication Adherence Rating Scale (MARS) Comparison of the pharmalogical adherence between pre-treatment and 12 months post-intervention within the two groups (PEPSUI versus Relaxation). At 12 months after the intervention
Secondary Adherence to treatment using the Medication Adherence Rating Scale (MARS) Comparison of the pharmacological adherence between pre-treatment and 18 months post-intervention within the two groups (PEPSUI versus Relaxation) At 18 months after the intervention
Secondary Adherence to treatment using the Medication Adherence Rating Scale (MARS) Comparison of the pharmacological adherence between pre-treatment and 24 months post-intervention within the two groups (PEPSUI versus Relaxation). At 24 months after the intervention
Secondary Perceived utility of mental health services using the likert scales rating from 0 (not useful at all) to 10 (very useful) Comparison of the number of missed consultations between pre-treatment and one week post-intervention within the two groups (PEPSUI versus Relaxation). At one week after the intervention
Secondary Perceived utility of mental health services using the likert scales rating from 0 (not useful at all) to 10 (very useful) Comparison of the number of missed consultations between pre-treatment and 6 months post-intervention within the two groups (PEPSUI versus Relaxation). At 6 months after the intervention
Secondary Perceived utility of mental health services using the likert scales rating from 0 (not useful at all) to 10 (very useful) Comparison of the number of missed consultations between pre-treatment and 12 months post-intervention within the two groups (PEPSUI versus Relaxation). At 12 months after the intervention
Secondary Perceived utility of mental health services using the likert scales rating from 0 (not useful at all) to 10 (very useful) Comparison of the number of missed consultations between pre-treatment and 18 months post-intervention within the two groups (PEPSUI versus Relaxation). At 18 months after the intervention
Secondary Perceived utility of mental health services using the likert scales rating from 0 (not useful at all) to 10 (very useful) Comparison of the number of missed consultations between pre-treatment and 24 months post-intervention within the two groups (PEPSUI versus Relaxation). At 24 months after the intervention
Secondary Depression intensity using the Inventory of Depressive Symptomatology (IDS-C30) Comparison of the intensity of depression between pre-treatment and one week post-intervention within the two groups (PEPSUI versus Relaxation). At one week after the intervention
Secondary Depression intensity using the Inventory of Depressive Symptomatology (IDS-C30) Comparison of the intensity of depression between pre-treatment and 6 months post-intervention within the two groups (PEPSUI versus Relaxation). At 6 months after the intervention
Secondary Depression intensity using the Inventory of Depressive Symptomatology (IDS-C30) Comparison of the intensity of depression between pre-treatment and 12 months post-intervention within the two groups (PEPSUI versus Relaxation). At 12 months after the intervention
Secondary Depression intensity using the Inventory of Depressive Symptomatology (IDS-C30) Comparison of the intensity of depression between pre-treatment and 18 months post-intervention within the two groups (PEPSUI versus Relaxation). At 18 months after the intervention
Secondary Depression intensity using the Inventory of Depressive Symptomatology (IDS-C30) Comparison of the intensity of depression between pre-treatment and 24 months post-intervention within the two groups (PEPSUI versus Relaxation). At 24 months after the intervention
Secondary Anxiety state using the State-Trait Anxiety Inventory (STAI-State) Comparison of the state of anxiety between pre-treatment and one week post-intervention within the two groups (PEPSUI versus Relaxation). At one week after the intervention
Secondary Anxiety state using the State-Trait Anxiety Inventory (STAI-State) Comparison of the state of anxiety between pre-treatment and 6 months post-intervention within the two groups (PEPSUI versus Relaxation). At 6 months after the intervention
Secondary Anxiety state using the State-Trait Anxiety Inventory (STAI-State) Comparison of the state of anxiety between pre-treatment and 12 months post-intervention within the two groups (PEPSUI versus Relaxation). At 12 months after the intervention
Secondary Anxiety state using the State-Trait Anxiety Inventory (STAI-State) Comparison of the state of anxiety between pre-treatment and 18 months post-intervention within the two groups (PEPSUI versus Relaxation). At 18 months after the intervention
Secondary Anxiety state using the State-Trait Anxiety Inventory (STAI-State) Comparison of the state of anxiety between pre-treatment and 24 months post-intervention within the two groups (PEPSUI versus Relaxation). At 24 months after the intervention
Secondary Psychological pain using the Likert scales from 0 (none) to 10 (maximum possible pain) Comparison of the psychological pain between pre-treatment and one week post-intervention within the two groups (PEPSUI versus Relaxation). At one week after the intervention
Secondary Psychological pain using the Likert scales from 0 (none) to 10 (maximum possible pain) Comparison of the psychological pain between pre-treatment and 6 months post-intervention within the two groups (PEPSUI versus Relaxation). At 6 months after the intervention
Secondary Psychological pain using the Likert scales from 0 (none) to 10 (maximum possible pain) Comparison of the psychological pain between pre-treatment and 12 months post-intervention within the two groups (PEPSUI versus Relaxation). At 12 months after the intervention
Secondary Psychological pain using the Likert scales from 0 (none) to 10 (maximum possible pain) Comparison of the psychological pain between pre-treatment and 18 months post-intervention within the two groups (PEPSUI versus Relaxation). At 18 months after the intervention
Secondary Psychological pain using the Likert scales from 0 (none) to 10 (maximum possible pain) Comparison of the psychological pain between pre-treatment and 24 months post-intervention within the two groups (PEPSUI versus Relaxation). At 24 months after the intervention
Secondary Hopelessness using the Beck Hopelessness Scale (BHS) Comparison of the hopelessness between pre-treatment and one week post-intervention within the two groups (PEPSUI versus Relaxation). At one week after the intervention
Secondary Hopelessness using the Beck Hopelessness Scale (BHS) Comparison of the hopelessness between pre-treatment and 6 months post-intervention within the two groups (PEPSUI versus Relaxation). At 6 months after the intervention
Secondary Hopelessness using the Beck Hopelessness Scale (BHS) Comparison of the hopelessness between pre-treatment and 12 months post-intervention within the two groups (PEPSUI versus Relaxation). At 12 months after the intervention
Secondary Hopelessness using the Beck Hopelessness Scale (BHS) Comparison of the hopelessness between pre-treatment and 18 months post-intervention within the two groups (PEPSUI versus Relaxation). At 18 months after the intervention
Secondary Hopelessness using the Beck Hopelessness Scale (BHS) Comparison of the hopelessness between pre-treatment and 24 months post-intervention within the two groups (PEPSUI versus Relaxation). At 24 months after the intervention
Secondary Global functioning using the Functioning Assessment Short Test (FAST) Comparison of the global functioning between pre-treatment and one week post-intervention within the two groups (PEPSUI versus Relaxation). At one week after the intervention
Secondary Global functioning using the Functioning Assessment Short Test (FAST) Comparison of the global functioning between pre-treatment and 6 months post-intervention within the two groups (PEPSUI versus Relaxation). At 6 months after the intervention
Secondary Global functioning using the Functioning Assessment Short Test (FAST) Comparison of the global functioning between pre-treatment and 12 months post-intervention within the two groups (PEPSUI versus Relaxation). At 12 months after the intervention
Secondary Global functioning using the Functioning Assessment Short Test (FAST) Comparison of the global functioning between pre-treatment and 18 months post-intervention within the two groups (PEPSUI versus Relaxation). At 18 months after the intervention
Secondary Global functioning using the Functioning Assessment Short Test (FAST) Comparison of the global functioning between pre-treatment and 24 months post-intervention within the two groups (PEPSUI versus Relaxation). At 24 months after the intervention
Secondary Quality of life evaluated by the World Health Organization Quality Of Life measure (WHOQOL-BREF) instrument Comparison of the quality of life between pre-treatment and one week post-intervention within the two groups (PEPSUI versus Relaxation). At one week after the intervention
Secondary Quality of life evaluated by the World Health Organization Quality Of Life measure (WHOQOL-BREF) instrument Comparison of the quality of life between pre-treatment and 6 months post-intervention within the two groups (PEPSUI versus Relaxation). At 6 months after the intervention
Secondary Quality of life evaluated by the World Health Organization Quality Of Life measure (WHOQOL-BREF) instrument Comparison of the quality of life between pre-treatment and 12 months post-intervention within the two groups (PEPSUI versus Relaxation). At 12 months after the intervention
Secondary Quality of life evaluated by the World Health Organization Quality Of Life measure (WHOQOL-BREF) instrument Comparison of the quality of life between pre-treatment and 18 months post-intervention within the two groups (PEPSUI versus Relaxation). At 18 months after the intervention
Secondary Quality of life evaluated by the World Health Organization Quality Of Life measure (WHOQOL-BREF) instrument Comparison of the quality of life between pre-treatment and 24 months post-intervention within the two groups (PEPSUI versus Relaxation). At 24 months after the intervention
Secondary Subjective social support using a Likert scale, from 0 (very poor quality) to 10 (excellent quality) Comparison of the subjective social support between pre-treatment and one week post-intervention within the two groups (PEPSUI versus Relaxation). At one week after the intervention
Secondary Subjective social support using a Likert scale, from 0 (very poor quality) to 10 (excellent quality) Comparison of the subjective social support between pre-treatment and 6 months post-intervention within the two groups (PEPSUI versus Relaxation). At 6 months after the intervention
Secondary Subjective social support using a Likert scale, from 0 (very poor quality) to 10 (excellent quality) Comparison of the subjective social support between pre-treatment and 12 months post-intervention within the two groups (PEPSUI versus Relaxation). At 12 months after the intervention
Secondary Subjective social support using a Likert scale, from 0 (very poor quality) to 10 (excellent quality) Comparison of the subjective social support between pre-treatment and 18 months post-intervention within the two groups (PEPSUI versus Relaxation). At 18 months after the intervention
Secondary Subjective social support using a Likert scale, from 0 (very poor quality) to 10 (excellent quality) Comparison of the subjective social support between pre-treatment and 24 months post-intervention within the two groups (PEPSUI versus Relaxation). At 24 months after the intervention
Secondary The need to emergency psychiatric consultation for suicidal ideation Comparison of need to emergency psychiatric consultation between pre-treatment and one week post-intervention within the two groups (PEPSUI versus Relaxation). At one week after the intervention
Secondary The need to emergency psychiatric hospitalisation for suicidal ideation Comparison of need to emergency psychiatric hospitalisation between pre-treatment and one week post-intervention within the two groups (PEPSUI versus Relaxation). At one week after the intervention
Secondary The need to emergency psychiatric consultation for suicidal ideation Comparison of need to emergency psychiatric consultation between pre-treatment and 6 months post-intervention within the two groups (PEPSUI versus Relaxation). At 6 months after the intervention
Secondary The need to emergency psychiatric hospitalisation for suicidal ideation Comparison of need to emergency psychiatric hospitalisation between pre-treatment and 6 months post-intervention within the two groups (PEPSUI versus Relaxation). At 6 months after the intervention
Secondary The need to emergency psychiatric consultation for suicidal ideation Comparison of need to emergency psychiatric consultation between pre-treatment and 12 months post-intervention within the two groups (PEPSUI versus Relaxation). At 12 months after the intervention
Secondary The need to emergency psychiatric hospitalisation for suicidal ideation Comparison of need to emergency psychiatric hospitalisation between pre-treatment and 12 months post-intervention within the two groups (PEPSUI versus Relaxation). At 12 months after the intervention
Secondary The need to emergency psychiatric consultation for suicidal ideation Comparison of need to emergency psychiatric consultation between pre-treatment and 18 months post-intervention within the two groups (PEPSUI versus Relaxation). At 18 months after the intervention
Secondary The need to emergency psychiatric hospitalisation for suicidal ideation Comparison of need to emergency psychiatric hospitalisation between pre-treatment and 18 months post-intervention within the two groups (PEPSUI versus Relaxation). At 18 months after the intervention
Secondary The need to emergency psychiatric consultation for suicidal ideation Comparison of need to emergency psychiatric consultation between pre-treatment and 24 months post-intervention within the two groups (PEPSUI versus Relaxation). At 24 months after the intervention
Secondary The need to emergency psychiatric hospitalisation for suicidal ideation Comparison of need to emergency psychiatric hospitalisation between pre-treatment and 24 months post-intervention within the two groups (PEPSUI versus Relaxation). At 24 months after the intervention
Secondary Acceptance assessment using the acceptance and Action Questionnaire (AAQII) Comparison of the acceptance between pre-treatment and one week post-intervention within the two groups (PEPSUI versus Relaxation). At one week after the intervention
Secondary Acceptance assessment using the acceptance and Action Questionnaire (AAQII) Comparison of the acceptance between pre-treatment and 6 months post-intervention within the two groups (PEPSUI versus Relaxation). At 6 months after the intervention
Secondary Acceptance assessment using the acceptance and Action Questionnaire (AAQII) Comparison of the acceptance between pre-treatment and 12 months post-intervention within the two groups (PEPSUI versus Relaxation). At 12 months after the intervention
Secondary Acceptance assessment using the acceptance and Action Questionnaire (AAQII) Comparison of the acceptance between pre-treatment and 18 months post-intervention within the two groups (PEPSUI versus Relaxation). At 18 months after the intervention
Secondary Acceptance assessment using the acceptance and Action Questionnaire (AAQII) Comparison of the acceptance between pre-treatment and 24 months post-intervention within the two groups (PEPSUI versus Relaxation). At 24 months after the intervention
Secondary Contact with the present moment assessment using the Mindful Attention Awareness Scale (MAAS) Comparison of the contact with the present moment between pre-treatment and one week post-intervention within the two groups (PEPSUI versus Relaxation). At one week after the intervention
Secondary Contact with the present moment assessment using the Mindful Attention Awareness Scale (MAAS) Comparison of the contact with the present moment between pre-treatment and 6 months post-intervention within the two groups (PEPSUI versus Relaxation). At 6 months after the intervention
Secondary Contact with the present moment assessment using the Mindful Attention Awareness Scale (MAAS) Comparison of the contact with the present moment between pre-treatment and 12 months post-intervention within the two groups (PEPSUI versus Relaxation). At 12 months after the intervention
Secondary Contact with the present moment assessment using the Mindful Attention Awareness Scale (MAAS) Comparison of the contact with the present moment between pre-treatment and 18 months post-intervention within the two groups (PEPSUI versus Relaxation). At 18 months after the intervention
Secondary Contact with the present moment assessment using the Mindful Attention Awareness Scale (MAAS) Comparison of the contact with the present moment between pre-treatment and 24 months post-intervention within the two groups (PEPSUI versus Relaxation). At 24 months after the intervention
Secondary Meaning in life assessment using the Life Regard Index: (LRI) Comparison of the meaning in life between pre-treatment and one week post-intervention within the two groups (PEPSUI versus Relaxation). At one week after the intervention
Secondary Meaning in life assessment using the Life Regard Index: (LRI) Comparison of the meaning in life between pre-treatment and 6 months post-intervention within the two groups (PEPSUI versus Relaxation). At 6 months after the intervention
Secondary Meaning in life assessment using the Life Regard Index: (LRI) Comparison of the meaning in life between pre-treatment and 12 months post-intervention within the two groups (PEPSUI versus Relaxation). At 12 months after the intervention
Secondary Meaning in life assessment using the Life Regard Index: (LRI) Comparison of the meaning in life between pre-treatment and 18 months post-intervention within the two groups (PEPSUI versus Relaxation). At 18 months after the intervention
Secondary Meaning in life assessment using the Life Regard Index: (LRI) Comparison of the meaning in life between pre-treatment and 24 months post-intervention within the two groups (PEPSUI versus Relaxation). At 24 months after the intervention
Secondary Satisfaction of the intervention using the Likert scales rating from 0 (not useful at all) to 10 (very useful) Evaluation of the satisfaction about the intervention within the two groups (PEPSUI versus Relaxation). One week after last session of the intervention within 15 days.
Secondary Adherence to the intervention (psychoeducational and relaxation ): number of sessions performed by the patient Comparison of adherence to the intervention within the two groups (PEPSUI versus Relaxation) assessed by the number of sessions performed by patients At one week after the intervention
See also
  Status Clinical Trial Phase
Recruiting NCT05609487 - Evaluation of the Safety Plan to Prevent Suicidal Reiteration N/A
Recruiting NCT06322199 - Differences Between Suicide Attempters and Suicide Ideators. Influence of the Brief Therapy Attempted Suicide Short Intervention Program (ASSIP) on Neuropsychological Correlates and Psychological Process Factors - Project 3
Completed NCT03134885 - Evaluation of a Regional Post-discharge Monitoring System for Suicide Attempters
Completed NCT01535482 - Cognitive Therapy for Suicidal Older Men N/A
Completed NCT01118208 - Blister Packaging Medication to Increase Treatment Adherence and Clinical Response N/A
Completed NCT01360736 - A Brief Intervention to Reduce Suicide Risk in Military Service Members and Veterans - Study 2 (SAFEMIL) N/A
Completed NCT05580757 - Pharmacists as Gate Keepers in Suicide Prevention: Needs of Pharmacists
Not yet recruiting NCT05427734 - Treating Drivers of Suicide Using Jaspr Health N/A
Recruiting NCT06406972 - Brief Admission by Self-referral for Individuals With Self-harm: Effects on Compulsory Care
Recruiting NCT05537376 - A Novel Peer-Delivered Recovery-Focused Suicide Prevention Intervention for Veterans With Serious Mental Illness N/A
Completed NCT03227991 - Safety Planning Intervention to Reduce Short Term Risk N/A
Recruiting NCT04962373 - Brief Admission for Adolescents Who Self-harm
Completed NCT02985047 - Brief Admission Skane: Replacing General Admission for Individuals With Self-harm and Acute Risk of Suicide N/A
Enrolling by invitation NCT06060535 - Implementation of Suicide Risk Models in Health Systems N/A
Recruiting NCT04994873 - Skills to Enhance Positivity in Suicidal Youth N/A
Recruiting NCT04592809 - Ketamine Versus Midazolam for Recurrence of Suicidality in Adolescents Phase 3
Completed NCT01176929 - Randomized Controlled and Prospective Trial of a Cohort of People Who Made a Suicide Attempt N/A
Completed NCT00558805 - Family Intervention for Suicidal Youth: Emergency Care Phase 2
Recruiting NCT05390918 - Targeting Adolescent Insomnia to Lessen Overall Risk of Suicidal Behavior N/A
Recruiting NCT04746261 - A Randomized Clinical Study of "Attempted Suicide Short Intervention Program" in Swedish Healthcare - ASSIP N/A